OGN

OrganonB

NYSE / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

Curated Events

Active

Recent Headlines

New

Materiality

90.25

Sentiment +88

Source

External coverage

Decided

2026-04-29

The payload explicitly says Sun Pharmaceutical Industries agreed to acquire Organon, and the impact hints identify OGN as the issuer-level target.

+0.1

30-day score

Company-55%

Macro-30%

Pulse-15%

The 30-day sentiment score is a decayed blend of Company, Macro, and Pulse components.

We are still collecting relevant articles for OGN. Curated events highlight the most material developments impacting this ticker right now.

As of 2026-05-30 • Updated scheduledSource: News desk